Jentashapir Journal of Health Research

Published by: Kowsar

Biotinidase, as a Convenient Diagnostic and Prognostic Marker for Breast Cancer

Nader Saki 1 , Soheila Nikakhlagh 1 and Gholamabbas Dinarvand 1 , *
Authors Information
1 Cancer Research Center, Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jentashapir Journal of Health Research: February 01, 2015, 6 (1); e27207
  • Published Online: February 21, 2015
  • Article Type: Discussion
  • Received: January 21, 2015
  • Accepted: February 2, 2015
  • DOI: 10.5812/jjhr.27207

To Cite: Saki N, Nikakhlagh S, Dinarvand G. Biotinidase, as a Convenient Diagnostic and Prognostic Marker for Breast Cancer, Jentashapir J Health Res. 2015 ;6(1):e27207. doi: 10.5812/jjhr.27207.

Abstract
Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Hypothesis
3. Consequences of the Hypothesis and Conclusion
Acknowledgements
Footnote
References
  • 1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009; 59(4): 225-49[DOI][PubMed]
  • 2. Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, et al. The case for early detection. Nat Rev Cancer. 2003; 3(4): 243-52[DOI][PubMed]
  • 3. Khatcheressian JL, Wolff AC, Smith TJ, Grunfeld E, Muss HB, Vogel VG, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006; 24(31): 5091-7[DOI][PubMed]
  • 4. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002; 1(11): 845-67[PubMed]
  • 5. Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, Hermjakob H, et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics. 2005; 5(13): 3226-45[DOI][PubMed]
  • 6. Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G. Breast cancer. Lancet. 2005; 365(9472): 1727-41[DOI][PubMed]
  • 7. Tuli R, Flynn RA, Brill KL, Sabol JL, Usuki KY, Rosenberg AL. Diagnosis, treatment, and management of breast cancer in previously augmented women. Breast J. 2006; 12(4): 343-8[DOI][PubMed]
  • 8. Aebersold R, Anderson L, Caprioli R, Druker B, Hartwell L, Smith R. Perspective: a program to improve protein biomarker discovery for cancer. J Proteome Res. 2005; 4(4): 1104-9[DOI][PubMed]
  • 9. Hartwell L, Mankoff D, Paulovich A, Ramsey S, Swisher E. Cancer biomarkers: a systems approach. Nat Biotechnol. 2006; 24(8): 905-8[DOI][PubMed]
  • 10. Iwaki H, Kageyama S, Isono T, Wakabayashi Y, Okada Y, Yoshimura K, et al. Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma -synuclein, and catechol-o-methyltransferase) identified by proteomic analysis. Cancer Sci. 2004; 95(12): 955-61[PubMed]
  • 11. Somiari RI, Somiari S, Russell S, Shriver CD. Proteomics of breast carcinoma. J Chromatogr B Analyt Technol Biomed Life Sci. 2005; 815(1-2): 215-25[DOI][PubMed]
  • 12. Lo WY, Tsai MH, Tsai Y, Hua CH, Tsai FJ, Huang SY, et al. Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin Chim Acta. 2007; 376(1-2): 101-7[DOI][PubMed]
  • 13. Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol. 2006; 24(8): 971-83[DOI][PubMed]
  • 14. Hu S, Loo JA, Wong DT. Human body fluid proteome analysis. Proteomics. 2006; 6(23): 6326-53[DOI][PubMed]
  • 15. Siriwardana G, Bradford A, Coy D, Zeitler P. Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase. Mol Endocrinol. 2006; 20(9): 2010-9[DOI][PubMed]
  • 16. Kim DH, Bae J, Lee JW, Kim SY, Kim YH, Bae JY, et al. Proteomic analysis of breast cancer tissue reveals upregulation of actin-remodeling proteins and its relevance to cancer invasiveness. Proteomics Clin Appl. 2009; 3(1): 30-40[DOI][PubMed]
  • 17. Chang JW, Kang UB, Kim DH, Yi JK, Lee JW, Noh DY, et al. Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer. Proteomics Clin Appl. 2008; 2(1): 23-32[DOI][PubMed]
  • 18. Thoma RW, Peterson WH. The enzymatic degradation of soluble bound biotin. J Biol Chem. 1954; 210(2): 569-79[PubMed]
  • 19. Wright LD, Driscoll CA, Boger WP. Biocytinase, an enzyme concerned with hydrolytic cleavage of biocytin. Proc Soc Exp Biol Med. 1954; 86(2): 335-7[PubMed]
  • 20. Pispa J. Animal biotinidase. Ann Med Exp Biol Fenn. 1965; 43-39[PubMed]
  • 21. Stanley JS, Griffin JB, Zempleni J. Biotinylation of histones in human cells. Effects of cell proliferation. Eur J Biochem. 2001; 268(20): 5424-9[PubMed]
  • 22. Hymes J, Fleischhauer K, Wolf B. Biotinylation of histones by human serum biotinidase: assessment of biotinyl-transferase activity in sera from normal individuals and children with biotinidase deficiency. Biochem Mol Med. 1995; 56(1): 76-83[PubMed]
  • 23. Narang MA, Dumas R, Ayer LM, Gravel RA. Reduced histone biotinylation in multiple carboxylase deficiency patients: a nuclear role for holocarboxylase synthetase. Hum Mol Genet. 2004; 13(1): 15-23[DOI][PubMed]
  • 24. Sarath G, Kobza K, Rueckert B, Camporeale G, Zempleni J, Haas E. Biotinylation of human histone H3 and interactions with biotinidase. FASEB J. 2004; 18(4)
  • 25. Wolf B, Grier RE, Allen RJ, Goodman SI, Kien CL. Biotinidase deficiency: the enzymatic defect in late-onset multiple carboxylase deficiency. Clinica Chimica Acta. 1983; 131(3): 273-81[DOI]
  • 26. Peters DM, Griffin JB, Stanley JS, Beck MM, Zempleni J. Exposure to UV light causes increased biotinylation of histones in Jurkat cells. Am J Physiol Cell Physiol. 2002; 283(3)-84[DOI][PubMed]
  • 27. Kothapalli N, Zempleni J. Double strand breaks of DNA decrease biotinylation of lysine-12 in histone H4 in JAr cells. FASEB J. 2004; 18(4)-4
  • 28. Kang UB, Ahn Y, Lee JW, Kim YH, Kim J, Yu MH, et al. Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker. BMC Cancer. 2010; 10: 114[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments